Palantir Guidance PLTR Spurs AI Deal Speculation

Palantir guidance ties FY2026 growth to the DoD Maven program of record and renewed auto partnerships that bolster pipeline and trader positioning.

April 01, 2026·2 min read
View all news articles
Flat-vector server cluster expanding forward to symbolize Palantir guidance and growing AI contract pipeline.

KEY TAKEAWAYS

  • Management guided FY2026 revenue to about $7.2B, implying roughly 61.0% growth.
  • Backlog totaled $4.4B and $1.3B in TCV bookings underpin multi-year revenue visibility.
  • DoD elevated the Maven Smart System to a program of record, converting pilots into budgeted workstreams.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Palantir guidance has reignited debate among traders and investors as late-March moves—the Pentagon's elevation of the Maven Smart System to program of record and a global Stellantis partnership—have strengthened the company's contract pipeline and growth outlook.

Quarter Results and Guidance

On December 31, 2025, Palantir Technologies reported fourth-quarter fiscal 2025 revenue of $1.4 billion, a 70.0% year-over-year increase. U.S. commercial revenue rose 137.0%, pushing total U.S. revenue above $1 billion. Management guided fiscal 2026 revenue to about $7.2 billion, implying roughly 61.0% growth, and signaled an expectation of sustaining annual expansion above 60% through 2027.

Contracts Backlog and Defense Wins

Palantir’s backlog stood at $4.4 billion, supported by $1.3 billion in total contract value bookings driven largely by long-term renewals. Remaining deal value reached $8.6 billion at year-end, up 91.0% year-over-year. Among key contracts, a 2025 U.S. Army enterprise agreement could be worth up to $10 billion at the high end.

In late March 2026, the Department of Defense elevated Palantir’s Maven Smart System to an official program of record, integrating it into ongoing military operations and securing long-term funding. That designation converts short-term pilots into budgeted workstreams, increasing revenue visibility.

Also in late March, Stellantis renewed and expanded a five-year partnership to deploy Palantir’s Foundry and AIP platforms across its global operations, adding to the company’s growing portfolio of AI deals in government and commercial sectors.

Balance Sheet and Analyst Reaction

As of December 31, 2025, Palantir held $7.2 billion in cash and equivalents and reported a current ratio of 7.11. Benchmark initiated coverage with a Hold rating, noting that avoiding downside risk would require sustained annual revenue growth in the 60%–70% range to justify the company’s valuation. Analyst consensus projects fiscal 2026 revenue growth of about 61.3% and 39.8% for 2027, with a non-GAAP earnings per share forecast of $1.32 for 2026. Some models extend to higher earnings by 2030, assuming continued expansion.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Micron Earnings Hit Record Q2 Results

Micron Earnings Hit Record Q2 Results

Micron earnings topped forecasts with a record Q2 and higher Q3 guidance, prompting traders to weigh upside versus heavy capex and cash-flow risk.

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 Results Show Sales Pressure

Cal-Maine Q3 results showed sales down as egg prices normalized and EPS beat while a pivot to specialty and prepared foods may steady earnings and trading

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston Earnings Lift Guidance, Cut Capex

Lamb Weston earnings beat adjusted EPS and lifted FY2026 sales midpoint while cutting capex to ~$400M, shifting investor focus toward cash generation.

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO Files Confidential SEC Submission

SpaceX IPO confidential filing signals a $75B raise and $1.75T target valuation that could shift capital into satellite and AI infrastructure

Lilly Foundayo FDA Approval Fuels GLP-1 Race

Lilly Foundayo FDA Approval Fuels GLP-1 Race

Lilly Foundayo FDA approval clears an oral GLP-1 that will ship via LillyDirect with low advertised pricing, accelerating access and pressuring rivals.

Beyond Meat Q4 2025 Earnings Miss, Sales Slide

Beyond Meat Q4 2025 Earnings Miss, Sales Slide

Beyond Meat Q4 2025 earnings showed weaker sales, collapsing margins and material weaknesses and set Q1 guidance, likely pressuring shares.